Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Nipro Pharma Corporation

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1NIPRO PHARMA CORPORATION

    02 3Nipro Consumer Healthcare

    03 1Nipro Diabetes Systems, Inc.

    04 1Nipro Pharma Corporation - Kagamiishi Plant

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    IMCAS World Congress
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IMCAS World Congress
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-12-15

    Nipro Pharma Corporation

    City : Iwase-Gun

    State :

    Country/Area : Japan

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-12-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    IMCAS World Congress
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IMCAS World Congress
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-11-06

    Nipro Pharma Corporation

    City : Kasukabe

    State :

    Country/Area : Japan

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-11-06

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    IMCAS World Congress
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IMCAS World Congress
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-06-05

    Nipro Pharma Corporation

    City : Lancaster

    State : NH

    Country/Area : U.S.A

    Zip : 03584-3103

    District : NWE

    Center : CFSAN

    Project Area : Food Composition, Standards, Lab...

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-06-05

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    IMCAS World Congress
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IMCAS World Congress
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2013-11-26

    Nipro Pharma Corporation

    City : Lancaster

    State : NH

    Country/Area : U.S.A

    Zip : 03584-3103

    District : NWE

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2013-11-26

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    IMCAS World Congress
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IMCAS World Congress
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2009-08-12

    Nipro Pharma Corporation

    City : Lancaster

    State : NH

    Country/Area : U.S.A

    Zip : 03584-3103

    District : NWE

    Center : CFSAN

    Project Area : Food Composition, Standards, Lab...

    District Decision : No Action Indicated

    Inspection End Date : 2009-08-12

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    IMCAS World Congress
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IMCAS World Congress
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2009-03-19

    Nipro Pharma Corporation

    City : Miramar

    State : FL

    Country/Area : U.S.A

    Zip : 33025-3932

    District : FLA

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2009-03-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Nipro Pharma Corporation and get a quotation

    Nipro Pharma Corporation is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Ceftobiprole Medocaril bulk offered by Nipro Pharma Corporation

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.